Logo.png
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss
March 28, 2024 08:00 ET | QHSLab, Inc.
WEST PALM BEACH, FL, March 28, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare...
Logo.png
QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results
November 14, 2023 08:30 ET | QHSLab, Inc.
25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit.  ●In Q3 2023, QHSLab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from...
Logo.png
QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance
May 24, 2022 08:00 ET | QHSLab, Inc.
WEST PALM BEACH, FL, May 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through...
Logo.png
QHSLab. Issues Update and Investor Presentation May 2022
May 09, 2022 08:30 ET | QHSLab, Inc.
  Superior Business Model and Strategic Position Validated By Repeat Ordering Client Base and New Developments to Product Portfolio   Addressable Market Opportunity Includes Over 250,000...
Logo.png
USA Equities Corp. Reports Fourth Quarter and Full Year 2021 Financial Results
April 05, 2022 08:00 ET | USA Equities Corp
Fourth Quarter 2021 Revenue Up 265% ●Revenue Surpassed $1.4 million for the year ended 2021 Compared to $124,000 for 2020●Gross Margin of 52% in Q4 Increased 1,200 Basis Points Versus Q4 2020●Strong...
Logo.png
QHSLab Expands Digital Prescription Product Portfolio in 2022
February 16, 2022 08:00 ET | USA Equities Corp
The company is introducing additional point-of-care digital healthcare and clinical decision-making tools into the market throughout the coming year.A major milestone includes the launch of the...
Logo.png
USA Equities Corp. Introduces AllergiQT™ – Quick Test, Further Expanding Market Presence
November 29, 2021 08:00 ET | USA Equities Corp
FDA-cleared and Easily Administered Skin Test for Environmental and Food Allergens; AllergiQT™ – Quick Test Targets Non-Allergy Specialists in Primary Care SettingsStrengthens USA Equities...
Logo.png
USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand
October 19, 2021 08:30 ET | USA Equities Corp
Strengthening Business Model and Expanding Product Portfolio in Large Addressable End MarketQ-Scale Represents a Compelling and Reimbursable Value Proposition for USAQ’s Physician ClientsFurther...
Logo.png
USA Equities Corp. Announces Strong Second Quarter 2021 Results
August 17, 2021 08:30 ET | USA Equities Corp
Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired AllergiEnd® Assets...
Logo.png
USA Equities Corp. Announces Strong Second Quarter 2021 Financial Results
July 15, 2021 07:30 ET | USA Equities Corp
 ● Revenue Grew 50% to $456,219 Compared to Q1 2021 ● Gross Margin of 46% Increased 164 Basis Points Versus Q1 2021 ● Strengthening of Company Financial Position and Strategic Relationships West Palm...